Furthermore, by downregulating the p65/Jun signaling pathway to control inflammatory responses, ICA can ameliorate abnormalities in collagen metabolism, which is beneficial for the structural damage and MF in rats with T2DM. The gene discussed is JUN; the disease is type 2 diabetes mellitus.